Structure-function relationships of the PEA3 group of Ets-related transcription factors

Biochemical and Molecular Medicine

Volumn 61, Issue 2, 1997, Pages 127-135

  De Launoit, Yvan ^c   Baert, Jean Luc ^a   Chotteau, Anne ^a,b   Monte, Didier ^a   Defossez, Pierre Antoine ^a   Coutte, Laurent ^a   Pelczar, Hélène ^a   Leenders, Frauke ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

BREAST CANCER; CANCER CELL; CANCER INVASION; CELL STIMULATION; CELL TRANSFORMATION; DNA BINDING; ORGANOGENESIS; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

MURINAE;

EID: 0031214665     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2605     Document Type: Article

References (47)

1. Crépieux P, Coll J, Stéhelin D. Ets family of proteins: Weak modulators of gene expression in quest of transcriptional partners. Crit Rev Oncol. 5:1994;615-638.
2. Karim F D, Urness L D, Thummel C S, Klemsz M J, McKercher S R, Celada A, Van Beveren C, Maki R A, Gunther K, Nye J A, Graves B J. The ETS domain: A new DNA binding motif that recognizes a purine-rich core sequence. Genes Dev. 4:1990;1451-1453.
3. Werner M H, Clore G M, Fisher C L, Fisher R J, Trinh L, Shiloach J, Gronenborn A M. The solution structure of the human ETS-1 DNA complex reveals a novel mode of binding and true side chain intercalation. Cell. 83:1995;761-771.
4. Shore P, Bisset L, Lakey J, Waltho J P, Virden R, Sharrocks A D. Characterization of the Elk-1 DNA-binding domain. J Biol Chem. 270:1995;5805-5811.
5. Laudet V, Niel C, Duterque M, Leprince D, Stehelin D. Evolution of theets. Biochem Biophys Res Commun. 190:1993;8-14.
6. Wasylyk B, Hahn S L, Giovane A. The Ets family of transcription factors. Eur J Biochem. 211:1993;7-18.
7. Janknecht R, Nordheim A. Gene regulation by Ets proteins. Biochim Biophys Acta. 1155:1993;346-356.
8. Xin J H, Cowie A, Lachance P, Hassell J A. Molecular cloning and characterization of PEA3, a new member of theEts. Genes Dev. 6:1992;481-496.
9. Higashino F, Yoshida K, Kamio K, Fujinaga K. Isolation of a cDNA encoding the adenovirus E1A enhancer binding protein: A new human member of theets. Nucleic Acids Res. 21:1993;547-553.
10. Brown T A, McKnight S L. Specificities of protein-protein and protein-DNA interaction of GABPα and two newly definedets. Genes Dev. 6:1992;2502-2512.
11. Jeon I-S, Davis J N, Braun B S, Sublett J E, Roussel M F, Denny C T, Shapiro D N. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 10:1995;1229-1234.
12. Monté D, Coutte L, Baert J L, Angeli I, Stéhelin D, de Launoit Y. Molecular characterization of the Ets-related human transcription factor ER81. Oncogene. 11:1995;771-779.
13. Monté D, Baert J L, Defossez P A, de Launoit Y, Stéhelin D. Molecular cloning and characterization of human ERM, a new member of the ETS family closely related to mouse PEA3 and ER81 transcription factors. Oncogene. 9:1994;1397-1406.
14. Monté D, Coutte L, Dewitte F, Defossez P A, Le Coniat M, Stéhelin D, Berger R, de Launoit Y. Genomic organization of the human ERM (ETV5) gene, a PEA3 group member of Ets transcription factors. Genomics. 35:1996;236-240.
15. Nakae K, Nakajima K, Inazawa J, Kitaoka T, Hirano T. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J Biol Chem. 270:1995;23795-23800.
16. Isobe M, Yamagishi F, Yoshida K, Higashino F, Fujinaga K. Assignment of the ets-related transcription factor E1A-F gene (ETV4) to human chromosome region 17q21. Genomics. 28:1995;357-359.
17. Osborne-Lawrence S, Welsch P L, Spillman M, Chandrasekharappa S C, Gallardo T D, Lovett M, Bowcock A M. Direct selection of expressed sequences within a 1-Mb region flanking BRCA1 on human chromosome 17q21. Genomics. 25:1995;248-255.
18. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature. 359:1992;162-165.
19. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker J M, Triche T J, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O. Combinatorial generation of variable fusion proteins in the Ewing family of tumors. EMBO J. 12:1993;4481-4487.
20. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J. A novel chimera gene betweenEWSE1A-F, Biochem Biophys Res Commun. 219:1996;608-612.
21. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, Sasaki Y, Ishida S, Higashino F, Jujinaga K. Fusion of an ETS-family gene, E1A-F, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer. 15:1996;115-121.
22. May W A, Lessnick S L, Braun B S, Klemsz M, Lewis B C, Lunsford L B, Hromas R, Denny C T. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol. 13:1993;7393-7398.
23. Braun B S, Frieden R, Lessnick S L, May W, Denny C T. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol. 15:1995;4623-4630.
24. Lessnick S L, Braun B S, Denny C T, May W A. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene. 10:1995;423-431.
25. Janknecht R. Analysis of the ERK-stimulated ETS-transcription factor ER81. Mol Cell Biol. 16:1996;1550-1556.
26. Janknecht R, Monté D, Baert D, de Launoit Y. The Ets-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Oncogene. 13:1996;1745-1754.
27. Laget M P, Defossez P A, Albagli O, Baert J L, Dewitte F, Stéhelin D, de Launoit Y. Two functionally distinct domains responsible for transactivation by the ETS family member ERM. Oncogene. 12:1996;1325-1336.
28. Fisher R J, Mavrothalassitis G, Kondoh A, Papas T S. High-affinity protein-DNA interactions of the cellular ETS1 protein: Determination of the ETS binding motif. Oncogene. 6:1991;2249-2254.
29. Woods D B, Ghysdael J, Owen M J. Identification of nucleotide preferences in DNA sequences recognized specifically byc-Ets. Nucleic Acids Res. 20:1992;699-704.
30. Zhang L, Lemarchandel V, Romeo P H, Ben-David Y, Greer P. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene. 8:1993;1621-1630.
31. Ray-Gallet D, Mao C, Tavitian A, Moreau-Gachelin F. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene. 11:1995;303-313.
32. Baert J L, Monté D, Musgrove E A, Albagli O, Sutherland R L, de Launoit Y. Expression of the PEA3 group of Ets-related transcription factors in human breast cancer cells. Int J Cancer. 70:1997;590-597.
33. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene. 10:1995;1461-1463.
34. Chen J H, Vercamer C, Li Z, Paulin D, Vandenbunder B, Stehelin D. PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene. 13:1996;1667-1675.
35. Y, de Launoit, M, Audette, S, Plaza, J, L, Baert, The ERM transcription factor activates the intercellular adhesion molecule-1 transcription through an Ets binding site.
36. P, A, Defossez, M, Monnot, Y, de Launoit, The ETS family member ERM contains an alpha helical acidic transactivation domain.
37. Schneikert J, Peterziel H, Defossez P A, Klocker H, de Launoit Y, Cato A CB. Androgen receptor-Ets protein interaction: A novel mechanism for steroid hormone mediated down modulation of matrix-metalloproteinase expression. J. Biol. Chem. 271:1996;23907-23913.
38. Janknecht R, Ernst W, Pingoud V, Nordheim A. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12:1993;5097-5104.
39. Whitmarsh A J, Shore P, Sharrocks A D, Davis R J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 269:1995;403-407.
40. O'Hagan R C, Tozer R G, Symons M, McCormick F, Hassell J A. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene. 13:1996;1323-1333.
41. Romano-Spica V, Suzuki H, Georgiou P, Chen S-L, Ascione R, Papas T S, Bhat N K. Expression ofets. Int J Oncol. 4:1994;521-531.
42. A, Chotteau-Lelièvre, X, Desbiens, H, Pelczar, P, A, Defossez, Y, de Launoit, Differential expression patterns of the PEA3 group transcription factors through embryonic development, Oncogene.
43. Scott G K, Daniel J C, Xiong X, Maki R A, Kabat D, Benz C C. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu. J Biol Chem. 269:1994;19848-19858.
44. Cardiff R D, Muller W J. Transgenic mouse models of mammary tumorigenesis. Cancer Surveys. 16:1993;97-113.
45. Trimble M S, Xin J H, Guy C T, Muller W J, Hassell J A. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene. 8:1993;3037-3042.
46. Liotta L A, Stetler-Stevenson W G. Metalloproteinases and cancer invasion. Semin Cancer Biol. 1:1990;99-106.
47. Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S, Fujinaga K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene. 12:1996;221-227.